Pharma reputation: building trust in the digital age
Date: Wednesday 1 May 2024
Event start: 8:00 am for 8.30am
Event finish: 12 noon.
How good is pharma’s reputation in Australia?
What do Aussies really think about the innovative medicines sector, and what can you do about it?
Whether it is a pandemic or (yet another) Netflix series on the US opioid crisis, the focus on pharma has never been more intense.
This exclusive MedNews event will dig deep into what Aussies think about companies and the sector, providing an opportunity to understand Aussie perceptions of pharma – and what they think you should be doing – while experts will discuss how you can positively impact both your sector and your brand.
The event will kick-off with a presentation on Australian research commissioned exclusively for MedNews looking at public perceptions of pharma reputation in Australia, followed by an expert panel discussion.
A second session will feature expert speaker Roger Christie who will discuss what leaders can do to impact the corporate reputation of their company, followed by a panel session featuring industry experts and leaders talking about how they either do (or do not) use social media.
The event is designed to both help industry sectors understand what people think of them, and to provide take-aways as to what they may do to improve perceptions.
Here is the start of our great line-up – and there’s more to come!
Roger is the founder of leading advisory firm Propel, which specialises in the use of LinkedIn in building a strong digital reputation for emerging and established leaders. With more than 15 years experience in digital communications, Roger has worked with a range of public and private sector organisations to help leaders build the skills they need to positively impact their personal and their company’s reputation.
Leah started her pharma career at Sanofi, rising to Vice President and Regional Head of JPAC before returning to Sydney in 2018. She later took on the role of MD and Country Speaker at Merck Healthcare during which time she was elected by her peers to sit on the Medicines Australia Board, and has also served as Managing Director of BMS Australia/NZ.
Through her career, her passion for ecosystem development and patient access has seen her leadership contribution to Industry Boards, policy working groups and biotech committees. Now CEO of leading industry consultancy Biointelect, Leah brings her extraordinary leadership experience across multiple facets of the industry to the event, able to share first-hand how as a senior leader who has worked in multiple markets she has tackled and developed reputational matters for the companies she has led.
A former principal of Boston Consulting Group in New York, Matt joined Novartis in 2014 as Director of Global Pharma Strategy in Basel and has enjoyed significant leadership opportunities since.
Going from Switzerland to the US to Hungary and now Australia where he is Novartis Country President Australia/New Zealand, Matt brings his exceptional leadership knowledge from both his pharma and business consulting to the event, along with his strong international perspective.
Nicola has enjoyed a 30-year career in the pharmaceutical industry working for Eli Lilly, Sanofi and MSD and is well known and highly regarded for her expertise and leadership in the public affairs, market access and policy spaces.
Nicola is founder of consultancy Strategic Cure and after having oversight of corporate reputation at MSD for more than a decade, brings her incredible knowledge and experience to the event as one of industry’s most respected voices in reputation management.
John is one of Australia’s most experienced healthcare communications strategists. Having previously managed the country’s largest public relations agency, John established Ethical Strategies in 2007 and now plays a hands-on role working across the agency’s key clients.
A dynamic strategist well-versed in the intricacy of multi-stakeholder communications, John is one industry’s most trusted advisors and brings both breadth and depth of experience to the conversation.
WHO SHOULD ATTEND
This event is for senior leaders and people working in and with pharma, MedTech and consumer health companies in Australia and New Zealand.
It is a must-attend event for CEOs/senior leaders wanting tools to better use social media to enhance their personal and their company’s reputation, along with professionals working in corporate, public affairs and government affairs roles, as well as patient engagement. In short, if your company’s reputation matters to you and your job, this is the event for you.
As well as being specifically geared for those wanting to impact the reputation of their company and their sector, the event is also an opportunity to network with others in your industry.
If you want to know more, contact email@example.com.